Concepedia

Amy Racine

AR

Statistics

Publications

11

Citations

1.3K

H-Index

11

Active since

1984

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Amy Racine is an author at Novartis (Switzerland) specializing in medicine, pharmacotherapy, and clinical trials.

Top concepts

Publications per year

1984–2018

11

Publications

11

Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

George D. Demetri, Yanfeng Wang, Elisabeth Wehrle et al. · Journal of Clinical Oncology · 2009 · 396 citations · Full text

, , +16

Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts

Frank Bretz, Heinz Schmidli, Franz König et al. · Biometrical Journal · 2006 · 257 citations

, , +15

Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma Group

Ian Judson, Peiming Ma, Bin Peng et al. · Cancer Chemotherapy and Pharmacology · 2004 · 191 citations

, , +8

Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry

Amy Racine, Andrew P. Grieve, H. Flühler et al. · Journal of the Royal Statistical Society Series C (Applied Statistics) · 1986 · 170 citations

Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Applications and Practical Considerations

Heinz Schmidli, Frank Bretz, Amy Racine et al. · Biometrical Journal · 2006 · 124 citations

1–5 of 11